Source: Eur Respir J, 52 (2) 1800537; 10.1183/13993003.00537-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Lorenzo Guglielmetti, Simon Tiberi, Matthew Burman, Heinke Kunst, Christian Wejse, Tamar Togonidze, Graham Bothamley, Christoph Lange. QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study. Eur Respir J, 52 (2) 1800537; 10.1183/13993003.00537-2018

Member's Comments

No comment yet.

Related content which might interest you: TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012 The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018 Year: 2019 European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Source: Eur Respir J 2002; 19: 765-775 Year: 2002 Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey Source: Eur Respir J 2008; 32: 1023-1030 Year: 2008 The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis Source: Breathe, 13 (3) e65; 10.1183/20734735.005517 Year: 2017 Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012 Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018 Year: 2018 Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study Source: Eur Respir J, 56 (1) 1902004; 10.1183/13993003.02004-2019 Year: 2020 Tuberculosis treatment outcome monitoring in European Union countries: systematic review Source: Eur Respir J 2013; 41: 635-643 Year: 2013 Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008 Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease Source: Eur Respir J 2016; 47:1345-1347 Year: 2016 Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe}, Source: Eur Respir J 2012; 40: 806-808 Year: 2012 Respiratory health and disease in Europe: the new European Lung White Book Source: Eur Respir J 2013; 42: 559-563 Year: 2013 National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Tuberculosis and HIV co-infection in European Union and European Economic Area countries Source: Eur Respir J 2011; 38: 1382-1392 Year: 2011 Evaluation of the accuracy of tuberculosis surveillance system by comparison with medical record in Korea Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Sustainability of Russian GLC approved projects and treatment success rate in Russian MDR-TB cohort 2010 Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation Source: Eur Respir J 2014; 43: 554-565 Year: 2013 Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014